Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11684622 Deuterated RUC-4

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

CeleCor Therapeutics

0

Current Assignee

CeleCor Therapeutics, Inc.

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Date of Patent

June 27, 2023

0

Patent Application Number

172534270

Date Filed

June 18, 2019

0

Patent Citations

US Patent 7517990 Method for deuteration of a heterocyclic ring

0

US Patent 9303044 7-(piperazin-1-yl)-5H-[1,3,4]thiadiazolo[3,2-A]pyrimidin-5-ones for the treatment of thrombotic disorders

0

US Patent 9532989 Oxadiazolo[3,2-A]pyrimidines and thiadiazolo[3,2-A]pyrimidines

0

Patent Primary Examiner

0

CPC Code

0

0

0

0

0

0

0

0

...

Provided herein are deuterated RUC-4 compounds, and related compositions and therapeutic methods.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11684622 Deuterated RUC-4

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool